Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00495066
Expanded Access Status : No longer available
First Posted : July 2, 2007
Last Update Posted : June 3, 2013
Information provided by (Responsible Party):
Bristol-Myers Squibb